1. O5 Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014. (23rd March 2020) Authors: Scherlinger, Marc; Mertz, Philippe; Sagez, Flora; Meyer, Alain; Felten, Renaud; Chatelus, Emmanuel; Javier, Rose-Marie; Sordet, Christelle; Martin, Thierry; Korganow, Anne-Sophie; Guffroy, Aurélien; Poindron, Vincent; Richez, Christophe; Truchetet, Marie-Elise; Blanco, Patrick; Schaeverbeke, Thie... Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus. Issue 7 (12th May 2022) Authors: Hisada, Ryo; Yoshida, Nobuya; Orite, Seo Yeon K.; Umeda, Masataka; Burbano, Catalina; Scherlinger, Marc; Kono, Michihito; Krishfield, Suzanne; Tsokos, George C. Journal: Arthritis & rheumatology Issue: Volume 74:Issue 7(2022) Page Start: 1204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Additional response to the correspondence: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Bennuci. Issue 4 (11th April 2019) Authors: Scherlinger, Marc; Schaeverbeke, Thierry Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 4(2019) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Response to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Benucci. Issue 4 (11th April 2019) Authors: Scherlinger, Marc; Schaeverbeke, Thierry Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 4(2019) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 'To switch or not to switch': the missing piece in the puzzle of biosimilar literature?. Issue 4 (4th January 2019) Authors: Scherlinger, Marc; Schaeverbeke, Thierry Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 4(2020) Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Role of stress in the development of rheumatoid arthritis: a case–control study. (13th June 2020) Authors: Germain, Vincent; Scherlinger, Marc; Barnetche, Thomas; Pichon, Clémence; Balageas, Alexandre; Lequen, Laurence; Shipley, Emilie; Foret, Jennifer; Dublanc, Stéphanie; Capuron, Lucile; Schaeverbeke, Thierry Journal: Rheumatology Issue: Volume 60:Number 2(2021) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Response to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Benucci. Issue 4 (26th January 2018) Authors: Scherlinger, Marc; Schaeverbeke, Thierry Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 4(2019) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study. Issue 7 (4th January 2019) Authors: Scherlinger, Marc; Carcaud, Claire; Truchetet, Marie-Elise; Barnetche, Thomas; Duffau, Pierre; Couzi, Lionel; Seneschal, Julien; Blanco, Patrick; Lazaro, Estibaliz; Richez, Christophe Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 7(2019) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect. Issue 1 (23rd October 2018) Authors: Germain, Vincent; Scherlinger, Marc; Barnetche, Thomas; Schaeverbeke, Thierry Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 1(2020) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Additional response to the correspondence: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Bennuci. Issue 4 (13th March 2018) Authors: Scherlinger, Marc; Schaeverbeke, Thierry Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 4(2019) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗